Literature DB >> 28648384

A novel and rapid method to quantify Treg mediated suppression of CD4 T cells.

Anna E Long1, Megan Tatum1, Carmen Mikacenic2, Jane H Buckner3.   

Abstract

Measuring regulatory T cell suppression provides important insight into T cell dysfunction in autoimmune disease. However, to date, suppression assays are limited by the requirement for freshly isolated cells, and significant cell numbers. Here, we present a novel and rapid in vitro assay using effector T cell surface expression of both CD25 and CD134 as a surrogate marker of regulatory T cell-mediated suppression. This surface marker-based suppression assay works for frozen samples and for samples with limited cell numbers. It is also shorter taking two days to complete compared to the four days required for proliferation-based assays. Furthermore, this assay works with both in vitro expanded and natural Tregs, as well as anti-CD3/anti-CD28 bead-based and APC stimulation conditions. In conclusion, we have developed and validated a new suppression assay for cryopreserved samples with limited cell numbers that may be helpful to investigate T cell regulation in the context of infection or autoimmune diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD134; CD25; Proliferation; Regulatory T cells; Suppression assay

Mesh:

Substances:

Year:  2017        PMID: 28648384      PMCID: PMC5573621          DOI: 10.1016/j.jim.2017.06.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  26 in total

1.  High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40).

Authors:  John J Zaunders; Mee Ling Munier; Nabila Seddiki; Sarah Pett; Susanna Ip; Michelle Bailey; Yin Xu; Kai Brown; Wayne B Dyer; Min Kim; Robert de Rose; Stephen J Kent; Lele Jiang; Samuel N Breit; Sean Emery; Anthony L Cunningham; David A Cooper; Anthony D Kelleher
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

2.  Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals.

Authors:  M Mardiney; M R Brown; T A Fleisher
Journal:  Cytometry       Date:  1996-12-15

Review 3.  Both integrated and differential regulation of components of the IL-2/IL-2 receptor system.

Authors:  Hyoung Pyo Kim; Jean Imbert; Warren J Leonard
Journal:  Cytokine Growth Factor Rev       Date:  2006-09-05       Impact factor: 7.638

4.  Cutting edge: Genetic variation in TLR1 is associated with Pam3CSK4-induced effector T cell resistance to regulatory T cell suppression.

Authors:  Carmen Mikacenic; Anya Schneider; Frank Radella; Jane H Buckner; Mark M Wurfel
Journal:  J Immunol       Date:  2014-11-05       Impact factor: 5.422

5.  Rapid assessment of in vitro expanded human regulatory T cell function.

Authors:  Joyce J Ruitenberg; Christopher Boyce; Ravi Hingorani; Amy Putnam; Smita A Ghanekar
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

Review 6.  CD40/CD40L signaling and its implication in health and disease.

Authors:  Antonios Chatzigeorgiou; Maria Lyberi; Gregorios Chatzilymperis; Adrianos Nezos; Elli Kamper
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

7.  Expression and distribution of CD11a/CD18 and CD54 during human T cell-B cell interactions.

Authors:  S Tohma; J E Ramberg; P E Lipsky
Journal:  J Leukoc Biol       Date:  1992-07       Impact factor: 4.962

Review 8.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.

Authors:  Wendy A Goodman; Alan D Levine; Jessica V Massari; Hideaki Sugiyama; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

10.  Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation.

Authors:  Min Wang; Dirk Windgassen; Eleftherios T Papoutsakis
Journal:  BMC Genomics       Date:  2008-05-16       Impact factor: 3.969

View more
  7 in total

1.  Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.

Authors:  Simi Ahmed; Karen Cerosaletti; Eddie James; S Alice Long; Stuart Mannering; Cate Speake; Maki Nakayama; Timothy Tree; Bart O Roep; Kevan C Herold; Todd M Brusko
Journal:  Diabetes       Date:  2019-07       Impact factor: 9.461

2.  Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis.

Authors:  Maryam Azimi; Mojdeh Ghabaee; Abdorreza Naser Moghadasi; Farshid Noorbakhsh; Maryam Izad
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

3.  Increased islet antigen-specific regulatory and effector CD4+ T cells in healthy individuals with the type 1 diabetes-protective haplotype.

Authors:  Xiaomin Wen; Junbao Yang; Eddie James; I-Ting Chow; Helena Reijonen; William W Kwok
Journal:  Sci Immunol       Date:  2020-02-14

4.  In vitro and In vivo CD8+ T Cell Suppression Assays.

Authors:  Lu Xie; Guihuan Liu; Yanjun Liu; Yuming Yu
Journal:  Bio Protoc       Date:  2021-05-20

5.  Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes.

Authors:  Joanne Boldison; Anna E Long; Rachel J Aitken; Isabel V Wilson; Clare Megson; Stephanie J Hanna; F Susan Wong; Kathleen M Gillespie
Journal:  Diabetologia       Date:  2021-10-28       Impact factor: 10.122

6.  IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.

Authors:  Carla J Greenbaum; Elisavet Serti; Katharina Lambert; Lia J Weiner; Sai Kanaparthi; Sandra Lord; Stephen E Gitelman; Darrell M Wilson; Jason L Gaglia; Kurt J Griffin; William E Russell; Philip Raskin; Antoinette Moran; Steven M Willi; Eva Tsalikian; Linda A DiMeglio; Kevan C Herold; Wayne V Moore; Robin Goland; Mark Harris; Maria E Craig; Desmond A Schatz; David A Baidal; Henry Rodriguez; Kristina M Utzschneider; Hendrik J Nel; Carol L Soppe; Karen D Boyle; Karen Cerosaletti; Lynette Keyes-Elstein; S Alice Long; Ranjeny Thomas; James G McNamara; Jane H Buckner; Srinath Sanda
Journal:  JCI Insight       Date:  2021-11-08

7.  Human regulatory T cells locally differentiate and are functionally heterogeneous within the inflamed arthritic joint.

Authors:  Lisanne Lutter; M Marlot van der Wal; Eelco C Brand; Patrick Maschmeyer; Sebastiaan Vastert; Mir-Farzin Mashreghi; Jorg van Loosdregt; Femke van Wijk
Journal:  Clin Transl Immunology       Date:  2022-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.